HealthSpring HS is well-positioned to emerge as an MA leader post-reform, Jefferies reports.
“HS' physician engagement model drives high compliance and quality (higher Stars),” Jefferies writes. “Member growth opportunities are attractive and the Bravo Health acquisition redoubles those opportunities.”
HealthSpring closed Friday at $28.75.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in